HARP - Harpoon Therapeutics EPS misses by $1.50 beats on revenue May, 06 2021 05:08 PM Harpoon Therapeutics Inc. Harpoon Therapeutics (HARP): Q1 GAAP EPS of -$1.95 misses by $1.50.Revenue of $9M (+172.7% Y/Y) beats by $2.39M.Press Release For further details see: Harpoon Therapeutics EPS misses by $1.50, beats on revenue